|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Non-current assets | |||||||||
| Investment properties | |||||||||
| Equity accounted investments | |||||||||
| Property, plant and equipment | |||||||||
| Goodwill | |||||||||
| Intangible assets | |||||||||
| Other non-current assets | |||||||||
| Loans and notes receivable | |||||||||
| Total non-current assets | |||||||||
| Current assets | |||||||||
| Loans and notes receivable | |||||||||
| Accounts receivable and other | |||||||||
| Cash and cash equivalents | |||||||||
| Total current assets | |||||||||
| Assets held for sale | |||||||||
| Total assets | |||||||||
| Liabilities and equity | |||||||||
| Non-current liabilities | |||||||||
| Debt obligations | |||||||||
| Capital securities | |||||||||
| Other non-current liabilities | |||||||||
| Deferred tax liabilities | |||||||||
| Total non-current liabilities | |||||||||
| Current liabilities | |||||||||
| Debt obligations | |||||||||
| Capital securities | |||||||||
| Accounts payable and other liabilities | |||||||||
| Total current liabilities | |||||||||
| Liabilities associated with assets held for sale | |||||||||
| Total liabilities | |||||||||
| Equity | |||||||||
| Limited partners | |||||||||
| General partner | |||||||||
| Preferred equity | |||||||||
| Non-controlling interests attributable to: | |||||||||
| Redeemable/exchangeable and special limited partnership units | |||||||||
| FV LTIP units of the Operating Partnership | |||||||||
| Interests of others in operating subsidiaries and properties | |||||||||
| Total equity | |||||||||
| Total liabilities and equity | |||||||||
Loading...
